NCT04178447View on ClinicalTrials.gov

Pharmacokinetic Profile of Glepaglutide After a Single Injection in Subjects With Varying Degrees of Renal Function

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 10, 2019

Primary Completion Date

July 14, 2020

Study Completion Date

July 14, 2020

Conditions
Renal Impairment
Interventions
DRUG

Glepaglutide

Single dose of Glepaglutide 10 mg

Trial Locations (3)

1077

Fázis I-es Klinikai Farmakológiai, Budapest

1115

Szent Imre Egyetemi Oktatókórház, Budapest

31-559

Specjalistyczne Centrum Medyczne - Prywatny Szpital, Krakow

Sponsors

Lead Sponsor

Zealand Pharma
All Listed Sponsors
lead

Zealand Pharma

INDUSTRY